Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading

Immunity

Volumn 4, Issue 4, 1996, Pages 357-366

  Riese, Richard J ^a   Wolf, Paula R ^b   Brömme, Dieter ^c   Natkin, Lisa R ^a   Villadangos, José A ^b   Ploegh, Hidde L ^b   Chapman, Harold A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Arris Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; B LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

EID: 0029931108     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80249-6     Document Type: Article

References (55)

1. Alteri, E., Bold, G., Cozens, R., Faessler, A., Klimkait, T., Lang, M., Lazdins, J., Poncioni, B., Roesel, J.L., Schneider, P., Walker, M., and Woods-Cook, K. (1993). CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity. Antimic. Ag. Chemotherap. 37, 2087-2092.
2. Amigorena, S., Drake, J. R., Webster, P., and Mellman, I. (1994). Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 349, 113-120.
3. Avva, R.R., and Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1, 763-774.
4. Bakke, O., and Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
5. Barrett, A. J., and Kirschke, H. (1981). Cathepsin B, Cathepsin H, Cathepsin L. Meth. Enzymol. 80, 535-560.
6. Bell, J.I., Estess, P., John, T.S., Saiki, R., Watling, D.L., Erlich, H.A., and McDevitt, H.O. (1985). DNA sequence and characterization of human class II major histocompatibility complex beta chains from DR1 haplotype. Proc. Natl. Acad. Sci. USA 82, 3405-3409.
7. Bénaroch, P., Yilla, M., Raposo, G., Ito, K., Miwa, K., Geuze, H.J., and Ploegh, H. (1995). How MHC class II molecules reach the endocytic pathway. EMBO J. 14, 37-49.
8. Bennett, K., Levine, T., Ellis, J.S., Peanasky, R.J., Samloff, I.M., Kay, J., and Chain, B.M. (1992). Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22, 1519-1524.
9. Bijlmakers, M.-J.E., Bénaroch, P., and Ploegh, H.L. (1994). Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180, 623-629.
10. Blum, J.S., and Cresswell, P. (1988). Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85, 3975-3979.
11. Brömme, D., and McGrath, M.E. (1996). High levels of expression of human cathepsin S and its crystallization. Protein Sci., in press.
12. Brömme, D., Steinert, A., Friebe, S., Fittkau, S., Wiederanders, B., and Kirschke, H. (1989). The specificity of bovine spleen cathepsin S. Scand. Biochem. J. 264, 475-481.
13. Brömme, D., Bonneau, P.R., Lachance, P., Wiederanders, B., Kirschke, H., Peters, C., Thomas, D.Y., Storer, A.C., and Vernet, T. (1993). Functional expression of human cathepsin S in Saccharomyces cerevisiae. J. Biol. Chem. 268, 4832-4838.
14. Buus, S., and Werdelin, O. (1986). A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. J. Immunol. 136, 452-458.
15. Chicz, R.M., Urban, R.G., Lane, W.S., Gorga, J.C., Stern, L.J., Vignali, D.A.A., and Strominger, J.L. (1992). Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358, 764-768.
16. Claesson, L., Larhammar, D., Rask, L., and Peterson, P.A. (1983). cDNA clone for the human γ chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl. Acad. Sci. USA 80, 7395-7399.
17. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers. Cell 82, 155-165.
18. Diment, S. (1990). Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 145, 417-422.
19. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
20. Humbert, M., Bertolino, P., Forquet, F., Rabourdine-Comb, C., Gerlier, D., Davoust, J., and Salamero, J. (1993). Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Eur. J. Immunol. 23, 3167-3172.
21. Lafuse, W.P., Brown, D., Castle, L., and Zwilling, B.S. (1995). IFN-γ increases cathepsin H mRNA levels in mouse macrophages. J. Leuk. Biol. 57, 663-669.
22. Lamb, C., and Cresswell, P. (1992). Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148, 3478-3482.
23. Larhammar, D., Gustafsson, K., Claesson, L., Bill, P., Wiman, K., and Rask, L. (1982). Alpha chain of HLA-DR transplantation antigens is a member of the same protein superfamily as the immunoglobulins. Cell 30, 153-161.
24. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V., and Peterson, P.A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
25. Maric, M.A., Taylor, M.D., and Blum, J.S. (1993). Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 91, 2171-2175.
26. Mason, R.W., Taylor, M.A.J., and Etherington, D.J. (1984). The purification and properties of cathepsin L from rabbit liver. Biochem. J. 217, 209-217.
27. Mason, R.W., Green, G.D.J., and Barrett, A.J. (1985). Human liver cathepsin L. Biochem. J. 226, 233-241.
28. Mason, R.W., Wilcox, D., Wikstrom, P., and Shaw, E.N. (1989). The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of specific radiolabelled inhibitor. Biochem. J. 257, 125-129.
29. Matsunaga, Y., Saibara, T., Kido, H., and Katunuma, N. (1993). Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 324, 325-330.
30. Morton, P.A., Zacheis, M.L., Giacoletto, K.S., Manning, J.A., and Schwartz, B.D. (1995). Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154, 137-150.
31. Neefjes, J.J., and Ploegh, H.L. (1992). Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J. 11, 411-416.
32. Newcomb, J.R., and Cresswell, P. (1993). Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J. Immunol. 151, 4153-4163.
33. Nguyen, Q.V., Knapp, W., and Humphreys, R.E. (1988). Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii. Human Immunol. 24, 153-163.
34. Palmer, J.T., Rasnick, D., Klaus, J.L., and Brömme, D. (1995). Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38, 3193-3196.
35. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A., and Cresswell, P. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-476.
36. Roche, P.A., and Cresswell, P. (1990). Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.
37. Roche, P.A., and Cresswell, P. (1991). Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88, 3150-3154.
38. Roche, P.A., Marks, M.S., and Cresswell, P. (1991). Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354, 392-294.
39. Rodriguez, G.M., and Diment, S. (1992). Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149, 2894-2898.
40. Rothbard, J.B., Lechner, R.I., Howland, K., Bal, V., Eckels, D.D., Sekaly, R., Long, E., Taylor, W.R., and Lamb, J.R. (1988). Structural model of HLA-DR1 restricted T cell antigen recognition. Cell 52, 515-523.
41. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.C., Barlow, A., and Janeway, C.A., Jr. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
42. Sette, A., Southwood, S., Miller, J., and Ettore, A. (1995). Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181, 677-683.
43. Shaw, S., Ziegler, A., and Demars, R. (1985). Specificity of monoclonal antibodies directed against human murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Human Immunol. 12, 191-211.
44. Sherman, M.A., Weber, D.A., and Jenson, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
45. Shi, G.-P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A. (1992). Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267, 7258-7262.
46. Shi, G.-P., Webb, A.C., Foster, K.E., Knoll, J.H.M., Lemere, C.A., Munger, J.S., and Chapman, H.A. (1994). Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269, 11530-11536.
47. Siegrist, C.-A., Martinez-Soria, E., Kern, I., and Mach, B. (1995). A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-γ. J. Exp. Med. 182, 1793-1799.
48. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
49. Steimle, V., Otten, L.A., Zuffrey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
50. Steimle, V., Siegrist, C.A., Mottet, A., Lisowska-Grospierre, B., and Mach, B. (1994). Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265, 106-109.
51. Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H.L., and Peters, J. (1994). Isolation and characterization of the intracellular MHC class II compartment. Nature 349, 120-126.
52. Van Noort, J.M., and van der Drift, A.C.M. (1989). The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J. Biol. Chem. 264, 14159-14164.
53. Van Noort, J.M., Boon, J., Van der Drift, A.C.M., Wagenaar, J.P.A., Boots, A.M.H., and Boog, C.J.P. (1991). Antigen processing by endosomal proteases determine which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur. J. Immunol. 21, 1989-1996.
54. West, M.A., Lucocq, J.M., and Watts, C. (1994). Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369, 147-151.
55. Wolf, P.R., and Ploegh, H.L. (1995). How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11, 267-306.